Companies: 10,795·Total market cap: $144.5T
Kezar Life Sciences, Inc.

Kezar Life Sciences, Inc.

KZRNASDAQHealthcare
$7.29
+$0.00(+0.00%)
Market Cap$53856333
P/E Ratio
52W High$7.55
52W Low$3.53
Overview

Kezar Life Sciences, Inc. (KZR) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · KZR · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-6.17kzr eps ttm · kzr earnings per shareEarnings history
PE Ratio (TTM)kzr pe ratio ttm · kzr price to earningsPE Ratio deep dive
Revenue (TTM)0.00kzr revenue ttm · kzr annual revenueFull revenue history
Dividend YieldNo Dividenddoes kzr pay dividends · kzr dividend yieldDividend history
Shares Outstanding7.3Mkzr shares outstanding · kzr floatShares outstanding history
Next EarningsAug 12, 2026Est.kzr earnings date · kzr next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
kezar life sciences, inc. revenue · kzr revenue 2025
FY 2025Net Income-$56.0M▲ +33.08% YoY
202320242025
kezar life sciences, inc. net income · kzr profit 2025
FY 2025EPS$-7.66▼ 566.09% YoY
202320242025
kzr eps · kezar life sciences, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$45.2MEPS: $-6.17View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold7 analystsis kzr a buy · kzr analyst rating
Strong Buy
0
Buy
2
Hold
5
Sell
0
Strong Sell
0
12-Month Price Target
$5.00Low
$7.29Current
$11.00Avg Target50.89% upside
$21.00High
kzr price target · kzr 12 month forecast

Total: 7 · Buy rate: 28.6%

The KZR analyst consensus is Hold, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $11.00, representing +50.89% upside from the current price of $7.29.

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+5.04%
YTD+15.90%
1Y+63.82%
5Y-98.71%

About Kezar Life Sciences, Inc.

CEOChristopher J. Kirk
IPO DateJun 21, 2018
Employees55
CountryUS

Kezar Life Sciences, Inc. is a United States-based clinical-stage biopharmaceutical company focused on identifying and advancing novel small molecule therapies. Its mission is to address significant u…

what is kezar life sciences, inc. · kzr stock overview · kezar life sciences, inc. company profile · who is kezar life sciences, inc. ceo · kzr NASDAQ · kezar life sciences, inc. headquarters · kezar life sciences, inc. business segments

About Stock Overview & Key Data

Kezar Life Sciences, Inc. (KZR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 21, 2018. As of the latest trading session, KZR stock price is $7.29, with a market capitalization of $53.9M. The stock has returned +63.82% over the past 12 months and +15.90% year-to-date.

According to 7 Wall Street analysts, the consensus rating for Kezar Life Sciences, Inc. stock is Hold, with an average 12-month price target of $11.00. In fiscal year 2025, Kezar Life Sciences, Inc. reported revenue of — and net income of -$56.0M. For detailed data — including Kezar Life Sciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Kezar Life Sciences, Inc. (KZR) stock price is $7.29. The stock is traded on NASDAQ under the ticker symbol KZR. The 52-week range is $3.53 – $7.55.

KZR stock priceKZR quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice